International Aids Vaccine Initiative INC.
Customers
2
2 federal agencies
Suppliers
5
5 federal subcontractors
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Federal obligations
$1.0M
FY2026 · USAspending.gov
Federal contracts 2
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $6.3M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Defense
Defense Threat Reduction Agency |
$5.3M | FY 2023 | 1 | HDTRA121C0005 | |
ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM | |||||
| Department of Health and Human Services
National Institutes of Health |
$1.0M | FY 2026 | 8 | $50.3M → $3.9M → $3.2M → $1.0M | 75N93019F00131 |
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 | |||||
Federal subcontractors 5
Companies this contractor subcontracted work to on federal prime contracts. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| Katinger Gmbh | $2.2M | FY 2025 | 1 | 75N93022F00001 | |
SINGLE-CELL CLONING, MASTER CELL BANKING, UPSTREAM & DOWNSTREAM PROCESS IMPLEMENTATION, ANALYTICAL TEST METHOD IMPLEMENTATION, CGMP MANUFACTURING AND SUPPLY OF A RECOMBINANT HIV-1 GP140 NANOPARTICLE VACCINE CANDIDATE TO SUPPORT PHASE 1 CLINICAL STUDI | |||||
| The Emmes Company, LLC | $1.8M | FY 2025 | 2 | 75A50121C00077 | |
C104 BDM STATEMENT OF WORK (MARBURG) | |||||
| Trustees Of Boston University | $1.1M | FY 2025 | 1 | 75A50121C00077 | |
NEIDL-BARDA SUDAN-NHP STUDY 2 | |||||
| Battelle Memorial Institute | $982.4K | FY 2025 | 1 | 75A50121C00077 | |
MARV/SUDV SHEDDING | |||||
| Batavia Biosciences INC. | $726.6K | FY 2025 | 3 | 75A50121C00077 | |
TO 44: RVSV΀?G-MARV-GP & RVSV΀?G-SUDV-GP: GMP DILUENT FILL AND STABILITY STUDIES | |||||
Alerts are coming
Get an email when International Aids Vaccine Initiative INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.